Hi everyone I'm Rose Marie Miller here with Derek Saul a breaking news reporter here at Forbes

here to tell us if weight loss drugs like Osmbeak will affect fitness stocks.

Thank you so much for joining me today Derek.

Yeah, excited talk.

So Derek, will they affect fitness stocks?

Short answer yes.

Yeah, I think it's it's very very early on in terms of adoption and I think we'll get into this more but I think

exercise stocks would definitely be kind of a effect

we'd see later down the line if it's okay now one's person is starting these drugs then

how's their behavior going to change but

based my research the answer is yes so why are analysts suggesting that it might be

beneficial for the fitness sector?

Yeah, so I would say it's twofold.

One, and again, it's early.

But research has suggested there's a Morgan Stanley

report that was out saying that Ozempick and other weight loss drug

users that they are exercising more frequently and not to not to try to play it too much of a armchair psychologist but I think it's okay if if a person is wanting to

Make a change and lose weight that they're likely going to also be engaging in behaviors that

would promote other health, want to exercise to maintain that weight loss whether they're or whether it's

after they're done with taking the drug or while they're still on and want to see

more results.

And so the second part is that if we're seeing people exercise more, that's going to be a good thing for

...